Skip to content

Ginkgo Bioworks DNA Short- and long-term operating lease liabilities

Short- and long-term operating lease liabilities at other companies

Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
-$125K-495%
Rumble, Inc. logo
Rumble, Inc.RUM
-$337.78K-40.4%
Mission Produce, Inc. logo
Mission Produce, Inc.AVO
-$2.8M-3.7%
The Baldwin Insurance Group, Inc. logo
The Baldwin Insurance Group, Inc.BWIN
-$4.74M-16.2%
NextNav logo
NextNavNN
$77K-63.7%
Target Hospitality logo
Target HospitalityTH
-$2.3M-33.9%

Other financials

Income statement

See full
Revenue$19.5M-49.1%
Gross profit$16.4M-52.0%
Operating income-$71.4M+11.9%
Net income-$82.6M+9.2%
EPS (diluted)-$1.42+27.6%

Balance sheet

See full
Cash & equivalents$188.7M-46.9%
Total debt$410.7M-5.5%
Total equity$443.2M-31.6%
Total assets$1.0B-20.1%

Cash flow

See full
Operating cash flow-$46.7M+9.4%
CapEx$1.9M-74.6%
Free cash flow-$48.6M+17.8%

Valuation

See full
Market cap$625.16M+24.6%
Enterprise value$847.19M+45.9%
P/S4.4×+2.2×

Profitability

See full
Operating margin-210.7%+7.6pp
Net margin-215.4%+8.3pp
FCF margin-119%-21.2pp

Returns & leverage

See full
Return on equity-55.8%-1.8pp
Debt / equity0.9×+0.3×
Current ratio5.2×+0.3×

Where this comes from

Reported directly by Ginkgo Bioworks in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.

The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ginkgo Bioworks's short- and long-term operating lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ginkgo Bioworks's short- and long-term operating lease liabilities?
Ginkgo Bioworks (DNA) reported short- and long-term operating lease liabilities of -$5M in Q1 2026.
How has Ginkgo Bioworks's short- and long-term operating lease liabilities changed year-over-year?
Ginkgo Bioworks's short- and long-term operating lease liabilities decreased by 4.3% year-over-year, from -$4.79M to -$5M.
What is the long-term trend for Ginkgo Bioworks's short- and long-term operating lease liabilities?
Over 2 years (2023 to 2025), Ginkgo Bioworks's short- and long-term operating lease liabilities has grown at a 10.7% compound annual growth rate (CAGR), from -$22.8M to -$27.93M.